Locations:
Search IconSearch

Research

Insulin vial

Stratifying Patients with Type 2 Diabetes for Targeted Intervention

High-need, high-cost patients identified in retrospective study

19-EMI-1348-WL-Calculator-CQD

Prediction Model Estimates Anticipated Weight Loss from Four Common Anti-Obesity Medications

Shared decision-making tool published in a recent study fills void

19-END-1288-Testosterone-CQD

Testosterone Replacement Therapy Does Not Increase or Decrease Cardiovascular Risk, Study Finds

Risks and rewards of supplementation must be carefully weighed for older men with secondary hypogonadism

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

19-END-1083-Cangliflozin-CQD

After Metabolic Surgery, Canagliflozin Reduces BMI and Blood Glucose Levels in Patients with Type 2 Diabetes

New study finds that the average patient can expect to lose an additional 3.5kg on canagliflozin

19-EMI-1203-Vitamin-D3-CQD

Vitamin D3 Supplementation Fails to Significantly Lower Diabetes Risk in Patients with Pre-diabetes

Study confirms gold standards of weight loss, nutrition and exercise for diabetes prevention

650×450-Obesity-GettyImages-500736880

Optimizing Diabetes Outcomes from Weight Loss Surgery: The First Year May Matter Most

Weight fluctuations after year one less important than percentage of weight loss in year one, study suggests

19-EMI-1084-Pantalone-Diabetes-650×450

Patient-Specific Therapy Selection Critical in Order to Avoid Intensification Inertia

New study explores intensification inertia in patients with diabetes and above-goal A1C levels

18-PAI-1187-Pain-Mgmt-Hero-Image_650x450pxl- (002)

SGLT2 Diabetes Meds and Amputations

A closer look at a recent study

BackPage 3 of 5Next

Advertisement

Ad